161 results about "Triglyceride" patented technology

This invention relates to the field of oil and fat synthesis technology, specifically to a method for preparing nervonic acid monoglyceride. In this invention, nervonic acid and glycerol are used as raw materials, and an esterification reaction is carried out under microwave assistance to obtain a first mixture containing nervonic acid monoglyceride, nervonic acid diglyceride, nervonic acid triglyceride, unreacted nervonic acid and glycerol, and a catalyst. Glycerol and the catalyst are removed by ethyl acetate extraction to obtain a second mixture. Subsequently, taking advantage of the temperature-sensitive nature of nervonic acid monoglyceride in edible oils, it is separated and purified to obtain nervonic acid monoglyceride. The esterification reaction under microwave assistance not only avoids the corrosion and contamination problems caused by traditional acid catalysts, but also significantly shortens the esterification reaction time, improves synthesis efficiency, and effectively inhibits the isomerization of cis-nervonic acid during the reaction, ensuring the stability of the product configuration.

This application relates to the field of functional composition technology, and in particular to a GABA-vitamin D neuroprotective composition and its preparation method, comprising medium-chain triglycerides, modified phospholipids, and a GABA-vitamin D blend. This application utilizes the low interfacial tension and strong amphiphilic compatibility of medium-chain triglycerides and modified phospholipids, enabling them to be miscible with the blend, thus improving the characteristics of GABA and vitamin D being easily degraded and oxidatively inactivated under complex physiological environments, and solving the problems of poor stability and asynchronous absorption. In the preparation method, the preferred component mass ratio is (0.6–1.5):1:(1–1.6), and mixing is carried out at 50–80°C for 10–60 min. The resulting system features high encapsulation efficiency, uniform particle size distribution, and high bioavailability. After treatment in simulated gastric fluid (pH 1.2) for 2 hours, the average GABA retention rate is ≥88% (optimal up to 94.3%), and the average vitamin D retention rate is ≥94% (optimal up to 96.8%). After treatment in simulated intestinal fluid (pH 6.8) for 4 hours, the simultaneous release rate of GABA and vitamin D is ≥90%, achieving precise intestinal delivery and making it suitable for industrial production.

This invention discloses a low-astringency prickly pear lactic acid bacteria fermented beverage and its application in lowering blood lipids and antioxidation, relating to the fields of microbial application and food fermentation technology. The fermented beverage of this invention uses prickly pear juice as raw material and is prepared by fermentation with *Lactobacillus plantarum* R-21. It can significantly reduce the tannin content of prickly pear juice, improve taste, and increase the polysaccharide content and antioxidant properties of the beverage. In vivo experiments show that it can reduce the levels of triglycerides, total cholesterol, and low-density lipoprotein cholesterol in mouse liver and serum, inhibit fat accumulation and fatty degeneration in liver cells, and enhance the activity of antioxidant enzymes in the liver, demonstrating important application value in lowering blood lipids and antioxidation.

This application relates to the field of veterinary drug technology, and discloses a transdermal absorption-enhancing ointment and its preparation process. The ointment components include white petrolatum, anhydrous lanolin, caprylic / capric triglycerides, hydrophobic fumed silica, and a highly fluid active permeation-enhancing phase. The permeation-enhancing phase contains active drugs and soybean lecithin, which self-assemble to form an inverse micelle aggregate. Soybean lecithin cross-links with the silanol groups on the surface of silica to form an intermolecular hydrogen bond network, constructing a sterically hindered framework within a continuous lipid matrix to prevent the polar drug-loaded phase from permeating and separating upon heating. Simultaneously, the inverse micelle structure effectively improves the transdermal absorption rate of the drug. The preparation process controls the lipid crystallization kinetics through slow cooling under negative pressure and micro-shear dynamic rheology. This invention solves the problems of easy precipitation upon heating, low transdermal efficiency, and poor rheological properties in traditional ointments, resulting in a product with a stable physical structure and good pseudoplastic texture.

This application relates to the field of feed processing technology and discloses a highly absorbable feed composition for nursery pigs containing compound probiotics. The composition includes the following ingredients: a basal diet, a live bacteria compound powder composed of freeze-dried *Lactobacillus plantarum* powder and freeze-dried *Bacillus coagulans* powder, medium-chain triglycerides, a PIT-responsive compound emulsifier composed of polysorbate-80 and sorbitan monooleate, anhydrous trehalose, glycerol, a micron-sized confinement carrier, which is a porous carrier obtained by high-temperature expansion and vacuum degassing of perlite powder, and fumaric acid. This invention employs anhydrous trehalose and glycerol to construct a high-permeability system, combined with medium-chain triglycerides and a compound emulsifier to form an oil-phase encapsulation, achieving the technical effect of effectively blocking external moisture penetration and improving the heat resistance of the bacteria.

The application discloses a kind of enveloped virus inactivation preparation based on medium-chain triglyceride and application thereof, the present application relates to the technical field of biological medicine external preparation, including active ingredient and auxiliary material: the active ingredient includes: high-purity medium-chain triglyceride (MCT), preferably octanoic acid (C8) and capric acid (C10) triglyceride mixture, purity ≥99%; The auxiliary material includes: food-grade antioxidant, for preventing oxidation of preparation, the content of food-grade antioxidant is 0.01-0.05%w / w, with medium-chain triglyceride as active ingredient, through the physical and chemical synergistic effect, enveloped virus is efficiently killed, for treating stubborn skin mucosa infection diseases (such as stubborn flat warts, herpes labialis, genital herpes, etc.) caused by human papillomavirus (HPV), herpes simplex virus (HSV-1 / HSV-2), varicella-zoster virus and other enveloped viruses.

The application discloses a concentrated tomato product for assisting in reducing blood fat and a preparation method thereof. The concentrated tomato product is prepared from the following raw materials in parts by weight: mature red tomatoes 800-1000 parts, phytosterols 8-12 parts, composite dietary fibers 3-8 parts, Omega-3 fatty acid microcapsules 2-6 parts, antioxidants 0.5-1.2 parts, stabilizers 0.3-0.8 parts, and edible buffer agents in an appropriate amount. The concentrated tomato product is concentrated juice or powder. The soluble solid content of the concentrated juice is 35-40 Bx, and the moisture content of the powder product is 5.0%. The application combines phytosterols, composite dietary fibers, Omega-3 fatty acid microcapsules and other natural functional components, and the components play a synergistic effect through different blood fat reduction mechanisms, thereby comprehensively assisting in regulating lipid indexes such as cholesterol and triglyceride. The blood fat reduction effect is significantly better than that of single-component products and ordinary tomato products, and the health needs of people with high blood fat can be met.

The present invention relates to a fat composition comprising at least 30 wt% of stearic acid (C18:0) and at least 45 wt% of saturated fatty acids (SAFA); and wherein the fat composition comprises 1.0 to 8.0 wt% of SSS triglycerides and at most 10.0 wt% of UUU triglycerides, and the weight ratio of S2U triglycerides to SSS triglycerides of the fat composition is 6.0 to 20.0 and the weight ratio of S2O triglycerides to S2L triglycerides is at most 30.0; wherein S is a saturated fatty acid, U is an unsaturated fatty acid, O is oleic acid and L is linoleic acid. The present invention further relates to a fat blend comprising the fat composition as hard stock, wherein the fat blend is further used in a water-in-oil emulsion product, such as a margarine or a spread.

The present disclosure related to the field of medicine. More particularly, the disclosure is in the field of treatment of diabetes, obesity, and / or dyslipidemia. The disclosure relates to compounds that agonize both the calcitonin and amylin receptors and can lower food intake, body weight, glucose and / or triglycerides, so can be used to treat diabetes, obesity and / or dyslipidemia. The present disclosure also includes pharmaceutical compositions containing such compounds and therapeutic uses of such compounds and compositions.

An oil-in-water microemulsion comprising water; an oil selected from an ester oil, a triglyceride, or combinations thereof; a liquid non-ionic surfactant having an HLB from 7 to 13, preferably, from 9 to 13, and more preferably, from 9 to 11; and a polyethylene glycol / polypropylene glycol / polyethylene glycol triblock polymer having an HLB value from 15 to 29, preferably, 15 to 28, and more preferably, 16 to 27, wherein the microemulsion is transparent and mono-phasic, and wherein the pH of the microemulsion is from 4.5 to 7.5, preferably, from 5 to 7, and more preferably, from 5.5 to 7.

To provide a novel material or composition that is effective in preventing or alleviating dyslipidemia. [Solution] A material or composition containing live or dead yeast cells or yeast hydrolysates for preventing or alleviating dyslipidemia. Dyslipidemia here refers to one or more abnormalities in blood concentrations of LDL cholesterol (bad cholesterol), HDL cholesterol (good cholesterol), and triglycerides (neutral fats). Zygosaccharomyces rouxii or Pichia are preferred as the yeast. The yeast is preferably of food origin and preferably intended for human consumption.

Disclosed in the invention are a type of compounds having activity of activating 5′-adenosine monophosphate-activated protein kinase (AMPK), a method for the preparation thereof, a pharmaceutical composition comprising the same, and use of these compounds in the manufacture of a medicament for reducing fatty acid synthesis, for inhibiting triglyceride and cholesterol synthesis, for preventing and / or treating obesity and type II diabetes, for preventing and / or treating tumor, for preventing and / or treating Parkinson's disease, for preventing and / or treating Alzheimer's disease or for prolonging the lifespan of mammals:

The present application provides a kind of kudzu vine cranberry composition for protecting liver from alcohol, which contains the following ingredients by weight: 30-50 parts of extract of Hovenia dulcis Thunb, 30-50 parts of mixed extract, 20-40 parts of extract of Pueraria lobata, 10-20 parts of extract of Poria cocos, 10-20 parts of extract of Glycyrrhiza uralensis, 0.05-0.1 parts of vitamin C; the raw materials of the mixed extract are mixed by cranberry and Fructus Lycii in a mass ratio of (1-2):(1-2). The present application further provides formulations and food containing the composition. The present application further protects the use of the composition or formulation in preparing health food or medicine with auxiliary protective effect on chemical liver injury. The composition provided by the present application can improve the activity of alcohol dehydrogenase / acetaldehyde dehydrogenase, reduce the content of MDA in tissues and increase the content of GSH, and reduce the content of triglyceride in liver cells, thereby comprehensively exerting the effect of protecting liver from alcohol, with high safety, small side effects, and wide sources of raw materials, and having important market value and development prospect.

This invention relates to ketogenic nutritional powder containing medium- and long-chain fatty acid triglycerides, its preparation method, and its application. It belongs to the field of food science and engineering technology. It uses enzymatically synthesized medium- and long-chain fatty acid triglyceride structured lipids as the sole fat source, which is different from the traditional physical mixture of long-chain triglycerides and medium- and long-chain oils. Medium-chain fatty acids and long-chain fatty acids are simultaneously bound to the same glycerol molecule. Fatty acid digestion and absorption are synchronized and metabolized, which can give full play to the synergistic nutritional advantages. It retains the characteristics of medium-chain fatty acids that provide rapid energy and are not easy to accumulate in body fat, while also supplementing essential fatty acids such as linoleic acid and α-linolenic acid. At the same time, it overcomes the disadvantages of pure medium-chain fatty acid oils that cause great gastrointestinal irritation and have a low smoke point.

This invention relates to *Lactobacillus paracasei* NEFU-5 and its applications, belonging to the field of biotechnology. To address the problems of limited functionality and poor direct degradation of metabolites in existing probiotic strains, this invention provides *Lactobacillus paracasei* NEFU-5 (accession number CCTCC NO: M 2026147). This *Lactobacillus paracasei* NEFU-5 can simultaneously and efficiently degrade uric acid, triglycerides, and cholesterol, and possesses excellent probiotic properties and safety. The *Lactobacillus paracasei* NEFU-5 provided by this invention can be used to prepare fermented products and can be used to prevent or improve hyperuricemia, hyperlipidemia, and other concurrent metabolic diseases, showing significant application prospects.

A ball screw grease composition for a rack-assisted electric power steering contains a thickener, a base oil, and at least one compound selected from the group consisting of a Ca sulfonates, fatty acids, and triglycerides, wherein the kinematic viscosity of the base oil at 40° C. is 4-100 mm2 / s, and the worked penetration of the composition is 265-385.

This invention relates to a nutritional composition for promoting bone development and its applications. The invention provides applications of the nutritional composition or preparations comprising said nutritional composition, including: (1) preparing food products; (2) preparing health products for promoting bone development, increasing height, and / or improving bone density; (3) preparing drugs or drug compositions for promoting bone development, increasing height, increasing bone density, treating or preventing osteoporosis, and / or treating or preventing skeletal dysplasia; and (4) promoting bone development, increasing height, and / or improving bone density for non-therapeutic purposes; wherein said nutritional composition comprises medium- and long-chain triglycerides (MLCT) and 1,3-diunsaturated fatty acid-2-palmitoyltriglycerides (UPU).

The present invention belongs to the field of functional foods, and specifically relates to a composition for lowering glucose and stabilizing an insulin level, a preparation method therefor, and use thereof. The composition of the present invention comprises a component I and a component II. The component I is cyclodextrin and a derivative thereof, the component II is naringenin and a derivative thereof, and the mass ratio of the component I to the component II is (0.1-100):(0.01-1). After being eaten with a meal or added to food, especially high-carbohydrate food, the composition of the present invention can significantly maintain the stability of the insulin level in the body while significantly controlling the postprandial blood glucose level. Long-term use can achieve the effects of stabilizing triglyceride, low-density lipoprotein, and high-density lipoprotein levels.

This invention provides a liquid crystal biomimetic water-locking and oxygen-permeable skincare composition, its preparation method, and its application, belonging to the field of cosmetic technology. It comprises the following components by weight percentage: 20-40% glycerin, 5-10% hydrogenated lecithin, 5-10% phytosterols, 0.1-0.5% sodium stearoyl glutamate, 0.01-0.05% sodium methylstearoyl taurate, 0.1-1% ceramide NP, 1-10% caprylic / capric triglyceride, 1-10% squalane, 0.1-1% tocopheryl acetate, 0.01-0.3% sodium DNA, 0.001-0.1% fibronectin, 0.001-0.1% soluble collagen, and the balance being water. The liquid crystal biomimetic water-locking and oxygen-permeable skincare composition provided by this invention can better form a breathable protective film on the skin surface, reduce skin moisture loss, and help repair damaged skin barriers, thereby achieving the effect of water-locking and oxygen-permeable skincare.

This invention provides an application of a nutritional composition for enhancing immunity. The nutritional composition of this invention comprises medium- and long-chain triglycerides (MLCT) and milk fat globule membrane (MFGM) in a mass ratio of 0.3:1 to 120:1. This nutritional composition can increase the proliferation of immune cells, and is used as a method for improving immunity.

The invention relates to an oral cannabinoid formulation comprising: a cannabinoid component comprising a cannabinoid; a carrier in the form of long chain triglyceride (LCT) or long chain fatty acid (LCFA); and a tocopheryl phosphate component comprising mono-(tocopheryl) phosphate (TP) and di-(tocopheryl) phosphate (T2P) wherein the mass ratio of the cannabinoid to the tocopheryl phosphate component is about 10:1 to 1:10.

The object of the present invention is to provide a viscosity index improver that, in a lubricating oil composition using ester oil, exhibits excellent viscosity-enhancing effect at 100°C, can lower the kinematic viscosity at 40°C, and has a high viscosity index-enhancing effect while considering the environment, such as biodegradability and environmental toxicity. [Solution] A viscosity index improver containing a poly(meth)acrylate polymer (A), an ester oil (B), and an ester oil (C), wherein the solubility parameter (SP value) of the poly(meth)acrylate polymer (A) is 8.95 to 9.15 (cal / cm³). 3 ) 1 / 2 The ester oil (B) is a diesterified product, and the solubility parameter (SP value) of the ester oil (B) is 8.80-8.95 (cal / cm³). 3 ) 1 / 2 The ester oil (C) is a glycerol triester, and the solubility parameter of the ester oil (C) is 8.90-9.00 (cal / cm³). 3 ) 1 / 2 A viscosity index improver.

This disclosure relates to the field of renewable oil compositions and to the use of renewable oil compositions for production of hydrocarbon compositions, which can be used for traffic fuels and other solutions. An exemplary composition contains free fatty acids and triglycerides, in a concentration of free fatty acids from 15 wt-% to 80 wt-% and a remainder being predominantly triglycerides. A method for producing hydrocarbons from a renewable oil feedstock, in which the feedstock which contains free fatty acids from 15 wt-% to 80 wt-%, and a remainder being predominantly triglycerides, is subjected to a pretreatment process followed by a hydrotreatment process for obtaining hydrocarbons.

The present invention relates to water-soluble laundry sheets and their use in textile cleaning. The water-soluble laundry sheets comprise a non-ionic surfactant, a triglyceride, and a hydrolyzed protein. The water-soluble laundry sheets improve the sweat buffering, wear comfort, and elasticity of the textile after laundering.

This invention belongs to the field of traditional Chinese medicine technology. More specifically, it relates to the application of a processed product of Citrus reticulata peel or Citrus reticulata peel embryo (with bitterness removed) in the preparation of products for lowering lipids and preventing and treating hyperlipidemia. Compared with the original product, the processed product of Citrus reticulata peel or Citrus reticulata peel embryo provided by this invention significantly reduces bitterness while significantly enhancing its effects in lowering cholesterol and triglycerides and regulating blood lipids. This processed product helps maintain normal levels of serum cholesterol, triglycerides, and low-density lipoprotein, and can significantly improve liver damage caused by hyperlipidemia, thus having important application value in lowering lipids and protecting the liver.

This invention relates to a medium-chain triglyceride nanocomposite emulsion and its preparation method, belonging to the field of nanoemulsion technology. The composite emulsion comprises medium-chain triglycerides, glycerol, an emulsifying agent, and deionized water, with an etherified CNF added as a stabilizer. It is synthesized via a two-step method: first, methacryloyl chloride is esterified with nanocellulose, and then reacted with thiolated polyethylene oxide via a UV-induced thiol-olefin click reaction, introducing a hydrophilic ether chain. This structure allows the stabilizer to be firmly anchored at the oil droplet interface and prevents aggregation through steric hindrance. During emulsion preparation, the stabilizer is first dispersed in the aqueous phase, then the oil phase is added for preliminary emulsification, and finally, high-pressure homogenization is performed. The emulsion obtained by this method has fine and uniform particle size, significantly improved stability, and is not prone to stratification under high temperature and long-term storage. It also exhibits excellent spreadability and a refreshing skin feel, making it suitable as a carrier for high-end cosmetics.

The application discloses a long-acting makeup holding foundation liquid, which comprises water, titanium dioxide, hydrogenated polydecene, isododecane, isohexadecane, dimethicone, caprylic acid / capric acid triglyceride, dipropylene glycol, silica, polyglyceryl-2 dipolyhydroxystearate, synthetic fluorphlogopite, polymethylsilsesquioxane, a film forming agent, magnesium sulfate, cetyl PEG / PPG-10 / 1 dimethicone, lithium montmorillonite, triethoxysilane, ethanol, dimethicone / vinyl dimethicone crosspolymer, alumina, dimethiconol, collagen, natural extract, a colorant, a moisturizing agent and trace additives. The long-acting makeup holding foundation liquid has reliable water supplementing and moisturizing and oil control effects, can selectively absorb and control oil, has reliable skin friendliness, can reliably protect makeup of oily skin, and avoids the problem of makeup removal caused by facial oil secretion.

This invention discloses a universal method and composition for solving the pilling problem in cold-formulated cosmetics. Adding an effective amount of glyceryl oleate, citrate / caprylic / capric triglyceride to a cosmetic composition containing a pilling-prone cold-formulated emulsifier can significantly reduce or eliminate pilling. This substance has been discovered for the first time to have a novel anti-pilling application, effective against pilling caused by the emulsifier's own characteristics, high dosage, electrolyte interference, or the addition of large molecules, and is universally applicable to different types of cold-formulated emulsifier systems. This invention is particularly suitable for systems using electrolyte-rich natural plant extracts as the aqueous phase, fundamentally solving the pilling problem and providing a reliable solution for preparing high-feel, all-natural cold-formulated cosmetics.

The application provides a water-oil double-layer penetration-promoting cosmetic composition and a preparation method thereof, and relates to the cosmetic field. The raw materials of the water-oil double-layer penetration-promoting cosmetic composition include 5-30% of an oil phase and 70-95% of an aqueous phase according to a total mass of 100%. The raw materials of the aqueous phase include dipropylene glycol, glycerol glucoside and water. The raw materials of the oil phase include caprylic capric triglyceride and isosorbide dioctanoate. The isosorbide dioctanoate in the water-oil double-layer penetration-promoting cosmetic composition constructs a lipid microchannel, the dipropylene glycol enhances the hydration of the stratum corneum, and the glycerol glucoside activates AQP3 water channel protein. The three channels synergistically improve the penetration efficiency without damaging the integrity of the skin barrier. The penetration-promoting agent has strong broad-spectrum penetration-promoting ability for different polar functional ingredients, the penetration-promoting effect is stable, and the penetration-promoting agent can be stably distributed in the oil and water phases.

A process for producing a treated, titanium dioxide pigment for use in a polymer composition is provided. The process comprises providing a plurality of titanium dioxide pigment particles, each of the particles having a surface, and depositing an organic treating agent on the surfaces of the pigment particles in an amount in the range of from about 0.2% to about 2% by weight, based on the weight of the pigment particles. The organic treating agent includes at least one medium-chain triglyceride. A treated, titanium dioxide pigment for use in a polymer composition, and a polymer composition, are also provided.